Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 100 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; sunset yellow fcf; purified water; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 75 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; purified water; sunset yellow fcf; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 75 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; purified water; sunset yellow fcf; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 50 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 50 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 25 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 25 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amantadine hydrochloride, quantity: 100 mg - capsule, soft - excipient ingredients: titanium dioxide; glycerol; lecithin; sodium propyl hydroxybenzoate; yellow beeswax; partially hydrogenated soya oil; iron oxide red; gelatin; sodium ethyl hydroxybenzoate; hydrogenated soya oil; rape seed oil; maize starch; sorbitol; mannitol; ethyl acetate; butan-1-ol; shellac; industrial methylated spirit - parkinson's disease: idiopathic parkinson's disease; post encephalitic parkinsonism; symptomatic parkinsonism (e.g. following cns injury from carbon monoxide poisoning); arteriosclerotic parkinsonism; drug-induced extrapyramidal reactions. symmetrel can be given alone for initial therapy or combined with anticholinergic drugs or l-dopa (see "dosage and administration"). note: symmetrel is not indicated for the treatment of tardive dyskinesia. type a virus influenza: prophylaxis of respiratory tract illness caused by influenza type a. prophylaxis in non-immunized individuals (including children) for whom influenza may have serious consequences (e.g. persons with chronic respiratory disease of diabetes mellitus).

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - silodosin, quantity: 8 mg - capsule, hard - excipient ingredients: mannitol; sodium lauryl sulfate; magnesium stearate; gelatin; titanium dioxide; pregelatinised maize starch - urorec is indicated for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia in adult men

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - silodosin, quantity: 4 mg - capsule, hard - excipient ingredients: mannitol; sodium lauryl sulfate; magnesium stearate; gelatin; titanium dioxide; iron oxide yellow; pregelatinised maize starch - urorec is indicated for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia in adult men